Export

Bristol-Myers Squibb Norway AS

Financial information

The information source is the annual report of the company with business id 891 297 262

* Closing information (×1000) NOK

Fiscal year 202312 202212
Turnover: 200,872 Revenue Up 157,484 Revenue Down
Financial expenses: 372 Revenue Down 495 Revenue Down
Earnings before taxes: 9,890 Revenue Up 7,976 Revenue Down
Total assets: 268,052 Revenue Up 251,702 Revenue Down
Current assets: 267,709 Revenue Up 251,553 Revenue Down
Current liabilities: 59,384 Revenue Up 51,705 Revenue Down
Equity capital: 208,668 Revenue Up 199,997 Revenue Up
Share capital: 1,000 Revenue Up 800

Financial ratios

Solvency: 77.8% Revenue Down 79.5% Revenue Up
Profitability: 4.9% Revenue Down 5.1% Revenue Up
Return on equity (ROE): 4.7% Revenue Up 4.0% Revenue Down
Current ratio: 450.8% Revenue Down 486.5% Revenue Up
Return on assets (ROA): 3.8% Revenue Up 3.4% Revenue Down
Fiscal year 202312
Turnover: 200,872
Financial expenses: 372
Earnings before taxes: 9,890
Total assets: 268,052
Current assets: 267,709
Current liabilities: 59,384
Equity capital: 208,668
Share capital: 1,000

Financial ratios

Solvency: 77.8%
Profitability: 4.9%
Return on equity (ROE): 4.7%
Current ratio: 450.8%
Return on assets (ROA): 3.8%